Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating ...

However, some mutations give cells a growth advantage, meaning they can clone cells with the same mutations. These patches have the potential to become the earliest stages of cancer. For the study, ...